Clinical evaluation of late outcomes in Dutch childhood cancer survivors: methodology of the DCCSS LATER study part 2
Elizabeth A. M. Feijen(Princess Máxima Center), Leontien C.M. Kremer(University Medical Center Utrecht), Andrica de Vries(Erasmus MC), Margriet van der Heiden(Princess Máxima Center), Margreet A. Veening(Amsterdam UMC Location Vrije Universiteit Amsterdam), Heleen Maurice‐Stam(Princess Máxima Center), Sebastian Neggers(Erasmus MC), Eline van Dulmen‐den Broeder(Erasmus MC), Jop C. Teepen(Princess Máxima Center), Martha A. Grootenhuis(University of Amsterdam), Marloes Louwerens(Leiden University Medical Center), Hanneke M. van Santen(University Medical Center Utrecht), Jaap den Hartogh(University of Lucerne), Birgitta Versluys(University Medical Center Utrecht), Cécile M. Ronckers(Johannes Gutenberg University Mainz), Dorine Bresters(Willem-Alexander Kinderziekenhuis), Wim J. E. Tissing(University Medical Center Groningen), Saskia M. F. Pluijm(Princess Máxima Center), Flora van Leuuwen(Radboud University Nijmegen), Helena van der Pal(Princess Máxima Center), Hanneke de Ridder-Sluiter(The Netherlands Cancer Institute), Marry van den Heuvel‐Eibrink(Princess Máxima Center), Jacqueline J. Loonen(Radboud University Nijmegen)
Cited by 4
Related Papers
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363